Advertisement

Related Videos

Deborah Collyar: What's In It for Patients?

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Advertisement

Advertisement




Jul
29
Today In Oncology
Germline Genetic Variants Associated With CAR T-Cell Therapy Safety and Efficacy in Hematologic Malignancies
FDA Approves SimpleScreen CRC Blood-Based Screening Test for Colorectal Cancer
MMUD vs MRD Transplantation in the Posttransplant Cyclophosphamide Era
Global Breast Cancer Survival Estimates: WHO Analysis
Concurrent Palliative Care Remains Underused Among Young Adults With Advanced Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo